Literature DB >> 16614989

Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect?

Stavros Giaglis1, Konstantinos Mimidis, Vassilios Papadopoulos, Konstantinos Thomopoulos, Prodromos Sidiropoulos, Stavros Rafail, Vassiliki Nikolopoulou, Eleni Fragouli, Georgios Kartalis, Athanasios Tzioufas, Dimitrios Boumpas, Konstantinos Ritis.   

Abstract

The MEFV gene, responsible for familial Mediterranean fever (FMF), is involved in inflammatory reactions through altered leukocyte apoptosis, secretion of interleukin (IL)-1beta, and activation of the NF-kappa B pathway. Ulcerative Colitis (UC) and FMF are both characterized by a recurrent pattern of presentation with periods of remission and flares associated with neutrophilic infiltration at the site of injury. The aim of this study was to investigate the possible correlation between UC and MEFV gene alterations. Twenty-five consecutive, first-diagnosed and untreated UC patients, 28 control patients with rheumatoid arthritis, and 65 normal individuals were analyzed. Nonisotopic RNase Cleavage Assay (NIRCA) was applied as a first-step mutational screening method of exons 10 and 2 of MEFV gene; direct sequencing was subsequently performed to confirm the results. MEFV mutations were identified in 7 (3 M694V/0, 2 M680I/0, 1 E148Q/E148Q, and 1 A744S/0) out of 25 UC patients versus 1 (M694V/0) out of 28 rheumatoid arthritis patients (P = .0199) and 1 (M694V/0) out of 65 healthy controls (P = .0004). Four out of 7 patients with MEFV mutations had inflammatory arthritis, a clinical finding that was not observed in the 18 UC patients with unmutated MEFV (P = .0028). Patients with UC almost universally carried the T A C G MEFV exon 2 haplotype in contrast with normal individuals (P < .0001) and FMF patients (P = .0310). In conclusion the increased frequency of mutations of MEFV in UC patients, especially in those with episodic arthritis, suggests a possible modifying effect of MEFV in the disease process and its localization within the joint. The difference in distribution of MEFV exon 2 haplotypes between UC patients and both FMF patients and normal individuals, suggests that UC patients constitute a genetically distinct population. Larger, longitudinal studies are needed to confirm these initial findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614989     DOI: 10.1007/s10620-006-3192-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 3.  Innate immunity and apoptosis in IBD.

Authors:  G Scott Lichtenberger; Richard A Flavell; Lena Alexopoulou
Journal:  Inflamm Bowel Dis       Date:  2004-02       Impact factor: 5.325

4.  The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease.

Authors:  Herma Fidder; Yehuda Chowers; Zvi Ackerman; Rivka Dresner Pollak; J Bart A Crusius; Avi Livneh; Simon Bar-Meir; Benjamin Avidan; Yael Shinhar
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

5.  Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis.

Authors:  Jae Jin Chae; Hirsh D Komarow; Jun Cheng; Geryl Wood; Nina Raben; P Paul Liu; Daniel L Kastner
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

6.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease.

Authors:  A Karban; E Dagan; R Eliakim; A Herman; S Nesher; B Weiss; D Berkowitz; R Shamir; R Gershoni-Baruch
Journal:  Genes Immun       Date:  2005-03       Impact factor: 2.676

8.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

Review 9.  Abdominal and digestive system associations of familial Mediterranean fever.

Authors:  Adam Mor; Rivka Gal; Avi Livneh
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

10.  Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.

Authors:  Christian Stehlik; Sug Hyung Lee; Andrea Dorfleutner; Angela Stassinopoulos; Junji Sagara; John C Reed
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

View more
  23 in total

Review 1.  TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis.

Authors:  Ian R Sanderson; W Allan Walker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-07-13       Impact factor: 4.052

2.  Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome.

Authors:  Donato Rigante; Piero Valentini; Roberta Onesimo; Donatella Francesca Angelone; Alessia De Nisco; Giulia Bersani; Angelica Bibiana Delogu
Journal:  Rheumatol Int       Date:  2009-05-20       Impact factor: 2.631

3.  The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still's disease.

Authors:  Fulya Cosan; Zeliha Emrence; Gokhan Erbag; Hulya Azakli; Baris Yilmazer; Ayten Yazici; Sema Sirma Ekmekci; Neslihan Abaci; Duran Ustek; Ayse Cefle
Journal:  Rheumatol Int       Date:  2012-12-27       Impact factor: 2.631

4.  Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.

Authors:  Deepika Sharma; Ankit Malik; Clifford S Guy; Rajendra Karki; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  Gastroenterology       Date:  2017-12-02       Impact factor: 22.682

Review 5.  Non-canonical manifestations of familial Mediterranean fever: a changing paradigm.

Authors:  Donato Rigante; Giuseppe Lopalco; Giusyda Tarantino; Adele Compagnone; Michele Fastiggi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-03-13       Impact factor: 2.980

6.  Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.

Authors:  Sahru Yüksel; Lilit Ayvazyan; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 7.  Autoinflammatory diseases: mimics of autoimmunity or part of its spectrum? Case presentation.

Authors:  Maria Helena B Kiss; Claudia Saad Magalhães
Journal:  J Clin Immunol       Date:  2008-03-20       Impact factor: 8.317

8.  MEFV heterogeneity in Turkish Familial Mediterranean Fever patients.

Authors:  Vasileios Papadopoulos; Ioannis Mitroulis; Stavros Giaglis
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

Review 9.  NOD-like receptors and inflammation.

Authors:  Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

10.  Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.

Authors:  Alexandra-Chloé Villani; Mathieu Lemire; Edouard Louis; Mark S Silverberg; Catherine Collette; Geneviève Fortin; Elaine R Nimmo; Yannick Renaud; Sébastien Brunet; Cécile Libioulle; Jacques Belaiche; Alain Bitton; Daniel Gaudet; Albert Cohen; Diane Langelier; John D Rioux; Ian D R Arnott; Gary E Wild; Paul Rutgeerts; Jack Satsangi; Séverine Vermeire; Thomas J Hudson; Denis Franchimont
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.